{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:04:59Z","timestamp":1769087099440,"version":"3.49.0"},"reference-count":113,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Consultation liaison psychiatrists are frequently asked to evaluate patients with altered mental status (AMS). Psychiatrists have unique perspectives and approaches to care for confused patients, particularly optimizing facilitation of care and maintaining vigilance for diagnostic overshadowing. Psychiatrists also offer expertise in primary psychiatric illnesses that can overlap with AMS, and the most common etiology of AMS is delirium. In this article, we provide a consultation liaison psychiatrist perspective on AMS and related psychiatric conditions in addition to delirium. Manic and psychotic episodes have primary and secondary etiologies, with some symptoms that can overlap with delirium. Catatonia, neuroleptic malignant syndrome, and serotonin syndrome are potentially fatal emergencies, and require prompt index of suspicion to optimize clinical outcomes. Trauma sequelae, functional neurologic disorders, and dissociative disorders can present as puzzling cases that require psychiatric facilitation of care. Additionally, AMS is sometimes due to substance intoxication and withdrawal in the hospital. A nonstigmatizing approach to evaluation and management of delirium and AMS can ensure optimal patient care experiences and outcomes.<\/jats:p>","DOI":"10.1055\/s-0044-1791226","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T23:09:26Z","timestamp":1727996966000},"page":"606-620","source":"Crossref","is-referenced-by-count":1,"title":["Psychiatric Etiologies and Approaches in Altered Mental Status Presentations: Insights from Consultation Liaison Psychiatry"],"prefix":"10.1055","volume":"44","author":[{"given":"Brandon","family":"Hamm","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2471\/BLT.12.115063","article-title":"No physical health without mental health: lessons unlearned?","volume":"91","author":"K Kolappa","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/0964704X.2014.887896","article-title":"Differentiation between seizure and hysteria in a tenth-century Persian text: Hid\u0101yat of al-Akhawayni (d. 983 AD)","volume":"23","author":"H Yarmohammadi","year":"2014","journal-title":"J Hist Neurosci"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaclp.2022.07.001","article-title":"An interdisciplinary reappraisal of delirium and proposed subtypes","volume":"64","author":"M A Oldham","year":"2023","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"ref4","first-page":"109","volume-title":"Psychotic disorders","author":"L J Rosenthal","year":"2019"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. 5th ed","author":"American Psychiatric Association","year":"2013"},{"issue":"26","key":"ref6","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","article-title":"Haloperidol for the treatment of delirium in ICU patients","volume":"387","author":"N C Andersen-Ranberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"26","key":"ref7","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical illness","volume":"379","author":"T D Girard","year":"2018","journal-title":"N Engl J Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/alz.13419","article-title":"Advancing specificity in delirium: the delirium subtyping initiative","volume":"20","author":"E ML Bowman","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-021-06009-0","article-title":"Effectiveness and safety of intravenous valproate in agitation: a systematic review","volume":"239","author":"M Olivola","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcrc.2016.09.006","article-title":"Valproate for agitation in critically ill patients: a retrospective study","volume":"37","author":"D J Gagnon","year":"2017","journal-title":"J Crit Care"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.ccm.0000908756.29426.21","article-title":"Pragmatic description of oral alpha-2 agonist SED in ICU sedation at a single tertiary care center","volume":"51","author":"K Sherman","year":"2023","journal-title":"Crit Care Med"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"e0785","DOI":"10.1097\/CCE.0000000000000785","article-title":"Effect of enteral guanfacine on dexmedetomidine use in the ICU","volume":"4","author":"M B Fetters","year":"2022","journal-title":"Crit Care Explor"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/ene.15441","article-title":"Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response","volume":"29","author":"S Vijiala","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2019.03.020","article-title":"Intravenous use of valproic acid in status epilepticus is associated with high risk of hyperammonemia","volume":"69","author":"J Lind","year":"2019","journal-title":"Seizure"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.eplepsyres.2021.106806","article-title":"Evaluation of levocarnitine, lactulose, and combination therapy for the treatment of valproic acid-induced hyperammonemia in critically ill patients","volume":"178","author":"C Nicholson","year":"2021","journal-title":"Epilepsy Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ajh\/2.6.468","article-title":"Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors","volume":"2","author":"I Coupry","year":"1989","journal-title":"Am J Hypertens"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: a master mechanism","volume":"28","author":"O D Howes","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mp.2017.170","article-title":"Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group","volume":"23","author":"S Kelly","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41398-022-02233-0","article-title":"The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia","volume":"12","author":"H Xu","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.20001","article-title":"Secondary psychoses: an update","volume":"12","author":"M S Keshavan","year":"2013","journal-title":"World Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.comppsych.2017.09.009","article-title":"Risk factors in early and late onset schizophrenia","volume":"80","author":"L Chen","year":"2018","journal-title":"Compr Psychiatry"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/schbul\/sbq125","article-title":"Delusional disorders \u2013 Are they simply paranoid schizophrenia?","volume":"38","author":"A Marneros","year":"2012","journal-title":"Schizophr Bull"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13546805.2023.2266872","article-title":"The association between visual hallucinations and secondary psychosis: a systematic review and meta-analysis","volume":"28","author":"G Blackman","year":"2023","journal-title":"Cogn Neuropsychiatry"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/npr2.12204","article-title":"Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: a consultation-liaison psychiatry service's experience","volume":"41","author":"Y Yagi","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","article-title":"Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects","volume":"171","author":"L L Judd","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/PCC.19m02549","article-title":"Organic psychosis causing secondary schizophrenia in one-fourth of a cohort of 200 patients previously diagnosed with primary schizophrenia","volume":"22","author":"J G Marques","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.neuropsych.15100376","article-title":"Lesion-related delusional misidentification syndromes: a comprehensive review of reported cases","volume":"28","author":"R Darby","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"114193","DOI":"10.1016\/j.ejmech.2022.114193","article-title":"Novel D2\/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment","volume":"232","author":"R Juza","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000007913","article-title":"Minor hallucinations in Parkinson disease: a subtle symptom with major clinical implications","volume":"93","author":"A Lenka","year":"2019","journal-title":"Neurology"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YCT.0000000000000501","article-title":"Long-term cognitive and psychological functioning in post-electroconvulsive therapy patients","volume":"35","author":"M L Miller","year":"2019","journal-title":"J ECT"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1570159X14666160606210811","article-title":"Depression and mania in bipolar disorder","volume":"15","author":"L Tondo","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"14","key":"ref32","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: a review","volume":"330","author":"A A Nierenberg","year":"2023","journal-title":"JAMA"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11920-011-0229-8","article-title":"Early detection and intervention in bipolar affective disorder: targeting the development of the disorder","volume":"13","author":"O D Howes","year":"2011","journal-title":"Curr Psychiatry Rep"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.2147\/NDT.S427617","article-title":"Functional alterations in patients with bipolar disorder and their unaffected first-degree relatives: insight from genetic, epidemiological, and neuroimaging data","volume":"19","author":"H Zhang","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1038\/s41380-021-01164-4","article-title":"Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders","volume":"26","author":"J R Osete","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mp.2016.260","article-title":"Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium","volume":"23","author":"S Stern","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamapsychiatry.2023.0131","article-title":"Association between the fronto-limbic network and cognitive and emotional functioning in individuals with bipolar disorder: a systematic review and meta-analysis","volume":"80","author":"R Mesbah","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jad.2007.12.001","article-title":"Delirious mania: clinical features and treatment response","volume":"109","author":"R Karmacharya","year":"2008","journal-title":"J Affect Disord"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.pra.0000426324.67322.06","article-title":"Delirious mania: clinical management in the acute setting","volume":"19","author":"N L Jacobowski","year":"2013","journal-title":"J Psychiatr Pract"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.genhosppsych.2020.03.003","article-title":"Delirious mania as a frequent and recognizable neuropsychiatric syndrome in patients with anti-NMDAR encephalitis","volume":"64","author":"M Restrepo-Martinez","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11126-009-9091-9","article-title":"Delirious mania and malignant catatonia: a report of 3 cases and review","volume":"80","author":"M B Detweiler","year":"2009","journal-title":"Psychiatr Q"},{"issue":"02","key":"ref42","first-page":"140","article-title":"Catatonia in the medically ill: etiology, diagnosis, and treatment","volume":"30","author":"L Denysenko","year":"2018","journal-title":"Ann Clin Psychiatry"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/15622975.2024.2312572","article-title":"Corticosteroids and mania: a systematic review","volume":"25","author":"M De Bock","year":"2024","journal-title":"World J Biol Psychiatr"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41398-020-0811-0","article-title":"Right-sided brain lesions predominate among patients with lesional mania: evidence from a systematic review and pooled lesion analysis","volume":"10","author":"J B Barahona-Corr\u00eaa","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"27","author":"T Kishi","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref46","first-page":"133","volume-title":"Depressive and manic syndromes","author":"E A Khawam","year":"2019"},{"issue":"05","key":"ref47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.biopsych.2021.07.008","article-title":"Treatment of psychiatric problems after traumatic brain injury","volume":"91","author":"J R Fann","year":"2022","journal-title":"Biol Psychiatry"},{"issue":"06","key":"ref48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1176\/ajp.150.6.916","article-title":"Secondary mania following traumatic brain injury","volume":"150","author":"R E Jorge","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1176\/appi.neuropsych.15080205","article-title":"Moria revisited: translation of Moritz Jastrowitz's description of pathologic giddiness","volume":"28","author":"J M Erickson","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psym.2020.08.003","article-title":"Clinical approach to personality change due to another medical condition","volume":"62","author":"I Leppla","year":"2021","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.psym.2018.11.009","article-title":"Acute pharmacological management of behavioral and emotional dysregulation following a traumatic brain injury: a systematic review of the literature","volume":"60","author":"R P Nash","year":"2019","journal-title":"Psychosomatics"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia","volume":"6","author":"S Walther","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology","volume":"37","author":"J P Rogers","year":"2023","journal-title":"J Psychopharmacol"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.psym.2018.04.001","article-title":"The probability that catatonia in the hospital has a medical cause and the relative proportion of its causes: a systematic review","volume":"59","author":"M A Oldham","year":"2018","journal-title":"Psychosomatics"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/15622975.2021.1925153","article-title":"Malignant catatonia: Severity, treatment and outcome - a systematic case series analysis","volume":"23","author":"M Cronemeyer","year":"2022","journal-title":"World J Biol Psychiatry"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/08850666221114303","article-title":"Malignant catatonia: A review for the intensivist","volume":"38","author":"J Connell","year":"2023","journal-title":"J Intensive Care Med"},{"issue":"06","key":"ref57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-3223(98)00109-7","article-title":"Serum iron in catatonia and neuroleptic malignant syndrome","volume":"44","author":"J W Lee","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1176\/appi.neuropsych.11060120","article-title":"Catatonic disorder due to a general medical or psychiatric condition","volume":"24","author":"J H Smith","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"110660","DOI":"10.1016\/j.jpsychores.2021.110660","article-title":"Clinical features of catatonic non-convulsive status epilepticus: a systematic review of cases","volume":"151","author":"K Ogyu","year":"2021","journal-title":"J Psychosom Res"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"e224017","DOI":"10.1136\/bcr-2017-224017","article-title":"Temporal glioblastoma presenting as catatonia","volume":"12","author":"A Franssen","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"G Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/JCP.0000000000001621","article-title":"Catatonia and delirium assessment of comorbidity, prevalence, and therapeutic response in medically ill inpatients from a university hospital","volume":"43","author":"F J Appiani","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/pcn.12168","article-title":"Do patients of delirium have catatonic features? An exploratory study","volume":"68","author":"S Grover","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/155005949502600108","article-title":"Clinical electroencephalograms in patients with catatonic disorders","volume":"26","author":"B T Carroll","year":"1995","journal-title":"Clin Electroencephalogr"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neubiorev.2020.02.006","article-title":"On the pathophysiology and treatment of akinetic mutism","volume":"112","author":"H Arnts","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2017.06.011","article-title":"Alternative treatment strategies for catatonia: a systematic review","volume":"48","author":"S R Beach","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2215-0366(18)30051-8","article-title":"Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies","volume":"5","author":"L Ludwig","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jts.20659","article-title":"Behavioral and molecular genetics of dissociation: the role of the serotonin transporter gene promoter polymorphism (5-HTTLPR)","volume":"24","author":"S Pieper","year":"2011","journal-title":"J Trauma Stress"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"e2318611","DOI":"10.1001\/jamanetworkopen.2023.18611","article-title":"Effect of dexmedetomidine on posttraumatic stress disorder in patients undergoing emergency trauma surgery: a randomized clinical trial","volume":"6","author":"Y Yu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"109418","DOI":"10.1016\/j.neuropharm.2023.109418","article-title":"Alleviating anxiety and taming trauma: novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder","volume":"226","author":"N Singewald","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"114840","DOI":"10.1016\/j.psychres.2022.114840","article-title":"An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update","volume":"317","author":"L A Bajor","year":"2022","journal-title":"Psychiatry Res"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2016.15070967","article-title":"Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial","volume":"173","author":"G Villarreal","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: a systematic review and meta-analysis","volume":"21","author":"J Guina","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)00821-2","article-title":"Complex post-traumatic stress disorder","volume":"400","author":"A Maercker","year":"2022","journal-title":"Lancet"},{"key":"ref76","volume-title":"Plum and Posner's Diagnosis of Stupor and Coma. 4th ed","author":"J B Posner","year":"2007"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2019.03.005","article-title":"Functional coma: two case reports and a review of the literature","volume":"60","author":"E Ryznar","year":"2019","journal-title":"Psychosomatics"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1017\/S1092852921000845","article-title":"Identifying functional cognitive disorder: a proposed diagnostic risk model","volume":"27","author":"L McWhirter","year":"2022","journal-title":"CNS Spectr"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"111447","DOI":"10.1016\/j.jpsychores.2023.111447","article-title":"Clinical signs in functional cognitive disorders: a systematic review and diagnostic meta-analysis","volume":"173","author":"V Cabreira","year":"2023","journal-title":"J Psychosom Res"},{"issue":"03","key":"ref80","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2215-0366(14)70279-2","article-title":"Dissociative amnesia","volume":"1","author":"A Staniloiu","year":"2014","journal-title":"Lancet Psychiatry"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70344-8","article-title":"Transient global amnesia: functional anatomy and clinical implications","volume":"9","author":"T Bartsch","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12888-016-0908-4","article-title":"A case series of 223 patients with depersonalization-derealization syndrome","volume":"16","author":"M Michal","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.150.7.1030","article-title":"Validity of the Dissociative Experiences Scale in screening for multiple personality disorder: a multicenter study","volume":"150","author":"E B Carlson","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40263-020-00767-9","article-title":"Antipsychotics and risk of neuroleptic malignant syndrome: a population-based cohort and case-crossover study","volume":"34","author":"K SJ Lao","year":"2020","journal-title":"CNS Drugs"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-015-0162-5","article-title":"Neuroleptic malignant syndrome: complications, outcomes, and mortality","volume":"24","author":"S Modi","year":"2016","journal-title":"Neurocrit Care"},{"issue":"11","key":"ref86","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1060028016657553","article-title":"Neuroleptic malignant syndrome","volume":"50","author":"D J Pileggi","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"V R Velamoor","year":"1998","journal-title":"Drug Saf"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00005053-199403000-00007","article-title":"Progression of symptoms in neuroleptic malignant syndrome","volume":"182","author":"V R Velamoor","year":"1994","journal-title":"J Nerv Ment Dis"},{"issue":"10","key":"ref89","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"J L Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"8760","key":"ref90","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0140-6736(91)90138-F","article-title":"Serum iron and neuroleptic malignant syndrome","volume":"338","author":"P I Rosebush","year":"1991","journal-title":"Lancet"},{"issue":"01","key":"ref91","first-page":"25","article-title":"Neuroleptic malignant syndrome","volume":"24","author":"S N Caroff","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"04","key":"ref92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/acps.13359","article-title":"A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome","volume":"144","author":"D Guinart","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/a-1046-1044","article-title":"Treatment of the neuroleptic malignant syndrome in international therapy guidelines: a comparative analysis","volume":"53","author":"C Sch\u00f6nfeldt-Lecuona","year":"2020","journal-title":"Pharmacopsychiatry"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/j.1440-1614.1999.00630.x","article-title":"Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases","volume":"33","author":"J N Trollor","year":"1999","journal-title":"Aust N Z J Psychiatry"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15563650.2020.1839662","article-title":"Fatal serotonin syndrome: a systematic review of 56 cases in the literature","volume":"59","author":"S Prakash","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"E W Boyer","year":"2005","journal-title":"N Engl J Med"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12796","article-title":"An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System","volume":"44","author":"H Nguyen","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00228-023-03596-z","article-title":"Serotonin syndrome: a pharmacovigilance comparative study of drugs affecting serotonin levels","volume":"80","author":"C Elli","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"09","key":"ref99","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"E JC Dunkley","year":"2003","journal-title":"QJM"},{"key":"ref100","first-page":"249","volume-title":"Addictions","author":"D Alapati","year":"2019"},{"issue":"03","key":"ref101","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccc.2017.03.012","article-title":"Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines","volume":"33","author":"J R Maldonado","year":"2017","journal-title":"Crit Care Clin"},{"issue":"01","key":"ref102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0033-3182(99)71268-5","article-title":"Competency evaluations on the consultation-liaison service. Some overt and covert aspects","volume":"40","author":"C Umapathy","year":"1999","journal-title":"Psychosomatics"},{"issue":"03","key":"ref103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psym.2020.01.005","article-title":"Personality-informed care: speaking the language of personality","volume":"61","author":"M A Oldham","year":"2020","journal-title":"Psychosomatics"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/JCE2020311076","article-title":"Do you believe in magic? Shove, don't nudge: advising patients at the bedside","volume":"31","author":"K V Iserson","year":"2020","journal-title":"J Clin Ethics"},{"issue":"02","key":"ref105","first-page":"169","article-title":"Relational autonomy as the key to effective behavioral change","volume":"20","author":"J K Walter","year":"2013","journal-title":"Philos Psychiatry Psychol"},{"issue":"05","key":"ref106","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.psym.2017.03.013","article-title":"Capacity evaluation requests in the medical setting: a retrospective analysis of underlying psychosocial and ethical factors","volume":"58","author":"S Pesanti","year":"2017","journal-title":"Psychosomatics"},{"issue":"03","key":"ref107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3928\/00485713-20210215-01","article-title":"Psychiatric facilitation of care when requested for assessment of decision-making capacity","volume":"51","author":"B Hamm","year":"2021","journal-title":"Psychiatr Ann"},{"issue":"10","key":"ref108","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198209023071011","article-title":"Sounding board. Psychiatric consultation masking moral dilemmas in medicine","volume":"307","author":"M Perl","year":"1982","journal-title":"N Engl J Med"},{"issue":"03","key":"ref109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0447.2008.01211.x","article-title":"\u2018Diagnostic overshadowing\u2019: worse physical health care for people with mental illness","volume":"118","author":"S Jones","year":"2008","journal-title":"Acta Psychiatr Scand"},{"issue":"05","key":"ref111","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1352\/0895-8017(2001)106<0416:DORAR>2.0.CO;2","article-title":"Diagnostic overshadowing reviewed and reconsidered","volume":"106","author":"D A Jopp","year":"2001","journal-title":"Am J Ment Retard"},{"issue":"04","key":"ref112","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jpm.12911","article-title":"Mental health bias in physical care: an integrative review of the literature","volume":"30","author":"A Hallyburton","year":"2023","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"11","key":"ref113","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/0004867419848035","article-title":"The clinical utility of structural neuroimaging in first-episode psychosis: a systematic review","volume":"53","author":"M Forbes","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"ref115","volume-title":"SAMHSA's concept of trauma and guidance for a trauma-informed approach","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"issue":"01","key":"ref116","doi-asserted-by":"crossref","first-page":"2178366","DOI":"10.1080\/10872981.2023.2178366","article-title":"Trauma-informed care in the emergency department: concepts and recommendations for integrating practices into emergency medicine","volume":"28","author":"A Greenwald","year":"2023","journal-title":"Med Educ Online"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T23:38:20Z","timestamp":1731454700000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":113,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791226","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}